CClinicalTrials.gg
CompletedNCT05736133Updated Mar 20, 2025

Determining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain - A Pilot Trial

An interventional study of Physiotherapist-led primary care model for hip and knee pain and Usual physician-led primary care model for hip and knee pain in Hip Osteoarthritis and Knee Osteoarthritis, sponsored by Jordan Miller, PT, PhD. Completed at 1 site in Canada. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-20.

Sponsored by Jordan Miller, PT, PhD · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
205
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This is a pilot cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.

Read the detailed description

Arthritis is one of the leading causes of pain, disability, and reduced quality of life in patients. Arthritis currently affects one in five Canadians (six million), which is expected to rise to nine million people by 2040. Osteoarthritis (OA) is the most common forms of arthritis, with hip and knee being two of the most common locations.

For most people, the first point of contact for their pain is their primary care provider. Due to the rise in patients seeking support at the primary care level, the shortage of primary care providers, and the high burden on these providers, patients often do not receive timely access to the care they require. A promising strategy is to have an integrated model of care where a physiotherapist (PT) is the first point of contact within interprofessional primary care teams. PTs can provide a comprehensive and efficient management strategy for patients presenting to their primary care provider with hip and knee pain complaints.

This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with hip and knee pain.

The primary objectives of this pilot study are:

  1. Determine the feasibility of participant recruitment, assessment procedures, and retention.
  2. Determine the feasibility of implementing a new PT led primary care model for hip and knee pain.
  3. Explore the perspectives of patient participants and HCPs related to their experiences and attitudes towards the new service delivery model, barriers/facilitators to implementation, perceived satisfaction, perceived value and impact on clinic processes and patient participant outcomes.
02

Conditions studied

  • Hip Osteoarthritis
  • Knee Osteoarthritis
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 205 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Jordan Miller, PT, PhD is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adults >= 19 years who ask to book a primary care visits where the primary reason is for hip or knee pain of any duration.

Exclusion criteria

Exclusion Criteria:

  • Cannot understand, read, and write English
  • Known cancer causing hip or knee pain
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
205 participants (actual)

Study arms

  • Experimental
    Physiotherapist-led primary care model for hip and knee pain

    The index intervention will incorporate a PT within the primary care team and make them available at the first point of contact for people with hip or knee pain. There will be 4 key components of this intervention: 1) Initial assessment and screening; 2) Brief individualized intervention at first visit; 3) Health services navigation; 4) Providing additional PT care for people with an unmet need (e.g., no insurance coverage for PT).

    Other: Physiotherapist-led primary care model for hip and knee pain

  • Active comparator
    Usual physician-led primary care model for hip and knee pain

    Participants will be seen by a primary care physician or a nurse practitioner, depending on the current practice at the clinic. Participants in both groups will be permitted to seek additional care outside of the primary care clinic.

    Other: Usual physician-led primary care model for hip and knee pain

Interventions

  • OtherPhysiotherapist-led primary care model for hip and knee pain

    1. Initial assessment and screening: The PT will provide a comprehensive assessment according to established clinical practice guidelines. 2. Brief individualized intervention at first visit: The PT intervention will be at the discretion of the PT to reflect real-world PT intervention. 3. Health services navigation: Participants will be provided with options available to them in their community for rehabilitation. For example, they may be referred to community PT for ongoing management or presented with group exercise options. Participants will be assessed regarding the need for specialist referrals or resources available to manage complex clinical presentations such as comorbidity or frailty. Participants may be referred to the primary care provider if no specialized services are needed or when the PT cannot provide a direct referral. All individuals may have their medications reviewed by a physician if deemed appropriate by the PT or requested by the participant.

  • OtherUsual physician-led primary care model for hip and knee pain

    The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.

06

What researchers measure

Primary outcomes

  1. Participant Recruitment Rate

    A full trial will be feasible if the investigators are able to recruit 1.5 participants per week per site over 20 weeks

    Time frame: 20 weeks

  2. Assessment Procedures

    The investigators consider ≥80% of all assessment items completed and a mean time for completion of ≤60 minutes acceptable.

    Time frame: 12 months

  3. Retention

    The investigators consider an attrition rate of ≤20% at 12-month follow-up successful. ≤35% attrition will be considered partially successful; however, additional retention strategies would be required for the full trial based on evidence that ≥20% attrition threatens trial validity

    Time frame: 12 months

  4. PT Treatment Fidelity

    Treatment fidelity will be measured through an audit of a PT fidelity checklist and electronic medical record (EMR) to determine the consistency of the care provided. An acceptable level of fidelity will be considered ≥80% for each intervention component.

    Time frame: 20 weeks

Secondary outcomes

  1. Self-Reported Functioning

    Self-report using the Lower Extremity Functional Scale (0-80 score with higher score representing higher function)

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  2. Self-Reported Pain Intensity

    Measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity.

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  3. Health-Related Quality of Life

    Measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life)

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  4. Pain Self Efficacy

    Confidence in abilities to participate in usual activities using the Pain Self Efficacy Questionnaire

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  5. Catastrophic Thinking

    Measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking)

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  6. Fear of Movement

    Measured using the Tampa Scale of Kinesiophobia (an 11-item questionnaire)

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  7. Depression Subscale

    Measured using the 2-Item Patient Health Questionnaire

    Time frame: Baseline and 3, 6, 9, and 12 months follow-up

  8. Global Rating of Change

    Measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning and positive scores indicating an improvement of physical functioning)

    Time frame: 3, 6, 9, and 12 months follow-up

  9. Satisfaction with Health Care

    Measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received)

    Time frame: 3, 6, 9, and 12 months follow-up

  10. Adverse Events

    Measured using an adverse events questionnaire that asks 1) if the participant has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced.

    Time frame: 3, 6, 9, and 12 months follow-up

  11. Health Care Accessibility

    Percentage of participants assessed within 48 hours of calling for an appointment

    Time frame: Baseline

  12. Health-Care Utilization - Consultations in Electronic Medical Record (EMR)

    Number of consultations with primary care team members for hip or knee pain (e.g., physicians, nurse practitioners, nurses, social workers, occupational therapists)

    Time frame: 12 months

  13. Health-Care Utilization Survey - Visits to health professionals

    Survey questions related to hip or knee pain: number of visits to health professionals outside the primary care team (e.g., chiropractors, massage therapists, occupational therapists, physiotherapists, chronic pain clinics)

    Time frame: 12 months

  14. Health-Care Utilization Survey - Medications

    Survey questions related to hip or knee pain: number of medications taken. Includes type of medication, dose, frequency

    Time frame: 12 months

  15. Health-Care Utilization Survey - Walk-In Clinic Visits

    Survey questions related to hip or knee pain: number of walk-in clinic visits outside of primary care centre

    Time frame: 12 months

  16. Health-Care Utilization Survey - Emergency Department Visits

    Survey questions related to hip or knee pain: number of emergency department visits

    Time frame: 12 months

  17. Health-Care Utilization Survey - Inpatient Hospital Stays

    Survey questions related to hip or knee pain: number of overnight hospital stays

    Time frame: 12 months

  18. Health-Care Utilization Survey - Surgeries, Procedures, Injections

    Survey questions related to hip or knee pain: number of surgeries, procedures, and injections

    Time frame: 12 months

  19. Health-Care Utilization Survey - Specialist Visits

    Survey questions related to hip or knee pain: number of visits to specialists

    Time frame: 12 months

  20. Health-Care Utilization Survey - Diagnostic Imaging

    Survey questions related to hip or knee pain: number of diagnostic images received

    Time frame: 12 months

  21. Process Outcome - Medications Prescibed

    Collected from the EMR: medications prescribed for hip or knee pain. Includes the type of medication prescribed

    Time frame: 12 months

  22. Process Outcome - Diagnostic Imaging Ordered

    Collected from the EMR: diagnostic images ordered for hip or knee pain

    Time frame: 12 months

  23. Process Outcome - Exercises Prescribed

    Collected from the EMR: exercises prescribed for hip or knee pain

    Time frame: 12 months

  24. Process Outcome - Education Provided

    Collected from the EMR: education provided for hip or knee pain

    Time frame: 12 months

  25. Process Outcome - Referrals to other health care providers (HCPs)

    Collected from the EMR: referrals to other HCPs (both internal and external to the primary health care team) for hip or knee pain

    Time frame: 12 months

  26. Process Outcome - Primary Care Visits

    Collected from the EMR: visits to the primary care team for hip or knee pain

    Time frame: 12 months

  27. Process Outcome - Notes to Employers or Insurers

    Collected from the EMR: notes provided to employers or insurers for hip or knee pain

    Time frame: 12 months

  28. Self-Report Time Lost

    Self-reported time lost from work, volunteering, homemaking, and educational activities

    Time frame: 12 months

  29. Assistance Needed

    Self-reported assistance needed, due to hip or knee pain, for self-care, housework, shopping, or transportation

    Time frame: 12 months

  30. Extra Expenses

    Any extra expenses incurred as a result of hip or knee pain. Self-report

    Time frame: 12 months

  31. Cost Outcomes

    Costs associated with all health utilization, self-reported time lost, assistance needed, and extra expenses. Will be presented as aggregate and time-specific costs

    Time frame: 12 months

Other outcomes

  1. Baseline Characteristics

    To describe the study population, the investigators will capture the following through the survey: age, sex, gender, duration of musculoskeletal pain, locations of pain, medications, comorbidities, current work status, income, rurality, and ethnicity.

    Time frame: Baseline

  2. Comorbidities

    Measured at baseline using the Functional Comorbidity Index (an 18-item list of comorbidities that are associated with physical functioning).

    Time frame: Baseline

  3. Chronicity of Pain

    Self-reported length of time since current and first incidence of hip or knee pain

    Time frame: Baseline

  4. Participant Treatment Fidelity

    Self-report adherence to PT advice

    Time frame: 3 months follow-up

07

Study locations

1 site
  • Queen's University
    Kingston, Ontario K7L 3N6, Canada
08

References and documents

Individual participant data

Plan to share: No — The is no plan to share individual IPD with other researchers

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05736133
Lead sponsor
Jordan Miller, PT, PhD
Collaborators
Canadian Institutes of Health Research (CIHR), The Arthritis Society, Canada
Responsible party
Jordan Miller, PT, PhD (Assistant Professor, School of Rehabilitation Therapy, Queen's University, Queen's University) — Sponsor-investigator
First posted
Feb 21, 2023
Start date
Oct 2, 2023
Primary completion
Jan 17, 2025
Completion
Jan 17, 2025
Last update
Mar 20, 2025

Study contacts

Jordan Miller, PhD
principal investigator · Queen's University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion